BRIACELL THERAPEUTICS CORP. Shareholders' Equity
BRIACELL THERAPEUTICS CORP. (BCTX) had Shareholders' Equity of -$3.78 million as of 2023-07-31, per its 10-K filed 2023-10-25.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-10-25
- 2023-07-31: Stockholders' Equity Attributable to Parent -$3.78M.
- 2023-04-30: Stockholders' Equity Attributable to Parent -$5.89M.
- 2023-01-31: Stockholders' Equity Attributable to Parent -$1.28M.
- 2022-10-31: Stockholders' Equity Attributable to Parent $10.33M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2023-07-31 | -$3.78M 10-K · filed 2023-10-25 |
| 2023-04-30 | -$5.89M 10-Q · filed 2023-06-14 |
| 2023-01-31 | -$1.28M 10-Q · filed 2023-06-14 |
| 2022-10-31 | $10.33M 10-Q · filed 2023-03-16 |
| 2022-07-31 | $10.33M 10-K · filed 2023-10-25 |
| 2022-04-30 | $9.96M 10-Q · filed 2023-06-14 |
| 2022-01-31 | $16.43M 10-Q · filed 2023-06-14 |
| 2021-10-31 | $1.58M 10-Q · filed 2023-03-16 |
| 2021-07-31 | $27.67M 10-K · filed 2023-10-25 |
| 2020-07-31 | -$2.74M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |